NorthStar Healthcare - McKesson Information

NorthStar Healthcare is a leading international supplier of generic pharmaceutical drugs and a wholly owned subsidiary of McKesson Corporation. NorthStar products are manufactured at established facilities that are registered with the U.S. Food and Drug Administration (FDA). NorthStar manufacture generic drugs in an efficient and cost-effective manner to generate increased savings for its diverse customer base in North America. In 2017, NorthStar started supplying UK customers as part of a European business development strategy. NorthStar customers include: • Independent Retail Pharmacy Owners across North America • Hospitals • Long-Term Care Pharmacies • National Retail Chains in North America • McKesson Owned Pharmacies in North America and Europe. The NorthStar generics portfolio is broad and continues to meet the wide-ranging, ever-growing needs of its customers. Since launching its first drug in September 2007, NorthStar has grown to become a significant growth driver for McKesson and its global sourcing strategy. McKesson Corporation (NYSE: MCK) is one of the biggest companies in the world, with revenues of $207 billion in 2017. McKesson is ranked 6th on the 2018 Fortune 500 list. McKesson was founded in 1833, and currently has 78,000+ employees globally. McKesson is an industry leader in: • Pharmaceutical distribution in North America and Europe • Medical-surgical distribution to alternate care sites • Generics pharmaceutical distribution • Business and clinical services for providers • Healthcare technology solution